PHAROS CAPITAL GROUP, LLC other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}
{{ Info.Homepage }}

Adviser Profile

As of Date:

03/15/2024

Adviser Type:

- Large advisory firm

Number of Employees:

21

of those in investment advisory functions:

11 -8.33%

Registration:

SEC, Approved, 10/7/2011

AUM:

1,138,830,519 2.52%

of that, discretionary:

1,091,412,541 -1.75%

Private Fund GAV:

1,091,412,543 -1.75%

Avg Account Size:

162,690,074 -12.12%

SMA’s:

NO

Private Funds:

6

Contact Info

615 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
1B 1B 973M 779M 584M 389M 195M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Recent News

East West Bancorp Inc.
03/31/2021

Irving Independent Director East West Bancorp, Inc., East West Bank, Civic Ventures, American Society on Aging, Encore.Org, Pharos Capital BDC, Inc. Rudolph I. Estrada Lead Independent Director ...

Wall Street Journal

Clostridium difficile Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
03/08/2021

New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clostridium difficile Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)" - https://www.reportlinker.com ...

Yahoo Finance

Clostridium difficile Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
03/08/2021

Companies covered: Danaher Corp, Pharos Capital Group, LLC , Meridian Bioscience Inc, bioMerieux SA, DiaSorin SpA and Others Countries covered: United States, United Kingdom, Germany, France ...

Yahoo Finance

International Women's Day 2021: How to shop and give back today
03/08/2021

The funds raised will go towards supporting The Prince’s Trust’s #ChangeAGirlsLife campaign, an initiative created to help support young women across the UK living in extremely challenging ...

yahoo.com

International Women's Day 2021: How to shop and give back today
03/08/2021

The funds raised will go towards supporting The Prince’s Trust’s #ChangeAGirlsLife campaign, an initiative created to help support young women across the UK living in extremely challenging circumstances.

Yahoo Finance

Clostridium difficile Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
03/08/2021

Companies covered: Danaher Corp, Pharos Capital Group, LLC , Meridian Bioscience Inc, bioMerieux SA, DiaSorin SpA and Others Countries covered: United States, United Kingdom, Germany, France ...

Yahoo Finance


Private Funds Structure

Fund Type Count GAV
Private Equity Fund 6 $1,091,412,543

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
POST ROAD GROUP LLC - - 1.0b - - - - 1.0b 1.5b 9
KEYHAVEN CAPITAL PARTNERS LIMITED - - 1.1b - - - - 1.1b 1.1b 16
NEW STATE CAPITAL PARTNERS - - 775.8m - - - - 775.8m 1.2b 12
ASCRIBE CAPITAL LLC - - 1.1b - - - - 1.1b 1.1b 5
PATRIOT FINANCIAL MANAGER, L.P. - - 1.0b - - - - 1.0b 1.0b 5
GREY ROCK ENERGY MANAGEMENT, LLC - - 397.7m - - - - 397.7m 397.7m 6
CENTRE PARTNERS MANAGEMENT LLC - - 1.0b - - - - 1.0b 1.3b 8
ANDROS CAPITAL PARTNERS LLC - - 1.2b - - - - 1.2b 1.2b 4
PENINSULA CAPITAL PARTNERS, L.L.C. - - 848.0m - - - - 848.0m 848.0m 3
CIVC PARTNERS - - 2.3b - - - - 2.3b 2.3b 16

Private Funds



Employees




Brochure Summary

Overview

Pharos Capital Group, LLC (“Pharos”) primarily manages private equity funds specializing in later-stage investing, and provides investment advice to Pharos’ clients: Pharos Capital Partners, LP, Pharos Capital Partners II-A, LP, Pharos Capital Partners III, LP, Pharos Capital Partners III- A, LP, Pharos Capital Partners IV, LP, and Pharos Capital Partners IV-A, LP (the “Funds”). Pharos’ investment advice is limited to the Funds. Under limited circumstances and at its discretion, Pharos may offer advisory services to separately managed accounts (each an “SMA”) (collectively with the Funds, the “Clients”). Pharos is an investment adviser with offices in Brentwood, Tennessee, Dallas, Texas, and Baltimore, Maryland. Pharos was formed as a Delaware limited liability company in 2011 and is principally owned by Kneeland C. Youngblood, Pharos’ Managing Partner. Pharos is a certified Minority Business Enterprise (MBE). Pharos provides discretionary portfolio management to the Funds. The Funds are not registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”), and the securities issued by the Funds are not registered under the Securities Act of 1933, as amended (the “Securities Act”). As an investment adviser, Pharos identifies investment opportunities and participates in the acquisition, management, monitoring and disposition of investments for the Funds. The Funds’ objective is to achieve attractive risk-adjusted returns by investing in high-growth companies, primarily through equity and equity-related instruments, as well as debt. In investing on behalf of the Funds, Pharos previously had a core focus on the healthcare and business service sectors, and now has a core focus on healthcare companies.
Within the healthcare industry, Pharos is focused on growing middle-market healthcare companies that aim to lower the cost of care, improve patient outcomes and/or expand access to care, predominantly in rural and underserved markets. Pharos seeks to make investments for the Funds that address one or more of the United Nations’ Sustainable Development Goals related to poverty, good health and well-being, inequality and sustainable communities and cities. Pharos primarily seeks to partner with management teams to take a substantial or controlling equity position in Fund portfolio companies through buyouts, recapitalizations, or staged growth investments. The Funds then use this position to assist the company in executing its growth strategy and to maximize the investment’s exit value. Pharos provides advice and personnel necessary for the Funds to execute such strategies. The investment strategy of the Funds is not tailored to any particular investors, and investors cannot impose restrictions on any of the Funds’ investments. For its SMA Clients, Pharos provides non-discretionary management services, making and executing investment recommendations in pursuit of the investment mandate(s) established in the advisory agreement that are tailored to the SMA’s specific needs, which generally includes U.S. Government bonds. SMA Clients may impose restrictions on investing in certain securities or types of securities. Pharos currently manages a total of $1,138,830,519 of Client assets, $1,091,412,541 of which are managed on a discretionary basis and $47,417,978 of which are managed on a nondiscretionary basis. Such amount is based upon the calculation of Client regulatory assets under management as of December 31, 2023.